We Strive to
Make A Difference

Health: 

• An estimated 2 billion people globally have a chronic disease
• About 35 million per year die from non-communicable diseases
• Another 10 million die from infectious diseases
• The world’s healthcare burden is massive and increasing

In clinical studies over the past 20 years, our licensed Immunitor oral pill immunotherapeutics have consistently proven the science and demonstrated superior safety and efficacy in diseases such as late-stage cancers, tuberculosis, HIV/AIDS, hepatitis.In many cases where other treatments have failed.

Key Capital is now working with Immunitor  towards product registrations and commercializations that will contribute to a better healthcare future.